WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

Market Cap	85.42B
Revenue (ttm)	105.74B
Net Income (ttm)	6.73B
Shares Out	13.20M
EPS (ttm)	509.86
PE Ratio	12.69
Forward PE	n/a
Dividend	100.00 (1.55%)
Ex-Dividend Date	Dec 27, 2024

Volume	374
Average Volume	15,930
Open	6,430.00
Previous Close	6,470.00
Day's Range	6,430.00 - 6,470.00
52-Week Range	5,610.00 - 10,230.00
Beta	0.72
RSI	39.33
Earnings Date	Mar 14, 2025

About KOSDAQ:330350

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name...

• Industry: Pharmaceutical Preparations
• Founded: 2004
• Employees: 121
• Stock Exchange: KOSDAQ
• Ticker Symbol: 330350

Financial Performance

In 2023, KOSDAQ:330350's revenue was 80.12 billion, an increase of 23.87% compared to the previous year's 64.68 billion. Earnings were 7.96 billion, an increase of 221.04%.